The aims of my research is: 1) to investigate metabolic signatures for the diagnosis and prognostication of human malignancies which may be more sensitive and specific than those now available in clinic. 2) to establish adjunct MRS and MRI protocols that may improve the accuracy of clinical pathology. 3) to develop linkages between ex vivo tumor evaluation and in vivo non-invasive diagnosis with MR technologies. .